Funding for this research was provided by:
AstraZeneca Pharmaceuticals LP (CSR 209922)
Received: 10 July 2019
Accepted: 23 October 2019
First Online: 12 November 2019
Ethics approval and consent to participate
: The study was approved by the Cedars-Sinai Medical Center Institutional Review Board (Pro40503). Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: M.S.K. and A.J. declare that they have no conflicts of interest. B.S. receives grant support from Alnylum, AppliedVR, Ironwood, Salix, Shire, and Takeda. B.S. also has ownership interest in MyTotalHealth and QTherapies and receives royalties for the Acoustic Esophago-Gastrointestinal Surveillance (AEGIS) biosensor.